Here, we found that KCTD10 had novel prognostic utility in the identical GIST cases that we examined ETV1 expression; patients with KCTD10-positive primary tumors had a better outcome than those with KCTD10-negative primary tumors (Figure 4). The gene discussed is KCTD10; the disease is gastrointestinal stromal tumor.